Doctor Alexander Assmann
Heinrich Heine University Medical School, Duesseldorf (Germany)
Very low-dose recombinant factor VIIa for optimized treatment of cardiovascular patients at high risk of hemorrhage
Event: ESC Congress 2016
Topic: Thrombosis and coagulation
Session: Antithrombotics in daily clinical practice
ESC 365 is supported by
